|
1
|
Elsabahy M, Nazarali A and Foldvari M:
Non-viral nucleic acid delivery: key challenges and future
directions. Curr Drug Deliv. 8:235–244. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jafari M, Soltani M, Naahidi S,
Karunaratne DN and Chen P: Nonviral approach for targeted nucleic
acid delivery. Curr Med Chem. 19:197–208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mudhakir D and Harashima H: Learning from
the viral journey: how to enter cells and how to overcome
intracellular barriers to reach the nucleus. AAPS J. 11:65–77.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lentacker I, Vandenbroucke RE, Lucas B,
Demeester J, De Smedt SC and Sanders NN: New strategies for nucleic
acid delivery to conquer cellular and nuclear membranes. J Control
Release. 132:279–288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pichon C, Billiet L and Midoux P: Chemical
vectors for gene delivery: uptake and intracellular trafficking.
Curr Opin Biotechnol. 21:640–645. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kawazu T, Kanzaki H, Uno A, Azuma H and
Nagasaki T: HVJ-E/importin-β hybrid vector for overcoming
cytoplasmic and nuclear membranes as double barrier for non-viral
gene delivery. Biomed Pharmacother. 66:519–524. 2012.PubMed/NCBI
|
|
7
|
Burke CW, Suk JS, Kim AJ, Hsiang YH,
Klibanov AL, Hanes J and Price RJ: Markedly enhanced skeletal
muscle transfection achieved by the ultrasound-targeted delivery of
non-viral gene nanocarriers with microbubbles. J Control Release.
162:414–421. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cool SK, Geers B, Lentacker I, De Smedt SC
and Sanders NN: Enhancing nucleic acid delivery with ultrasound and
microbubbles. Methods Mol Biol. 948:195–204. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Geis NA, Katus HA and Bekeredjian R:
Microbubbles as a vehicle for gene and drug delivery: current
clinical implications and future perspectives. Curr Pharm Des.
18:2166–2183. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou Y, Yang K, Cui J, Ye JY and Deng CX:
Controlled permeation of cell membrane by single bubble acoustic
cavitation. J Control Release. 157:103–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miller AM, Munkonge FM, Alton EW and Dean
DA: Identification of protein cofactors necessary for
sequence-specific plasmid DNA nuclear import. Mol Ther.
17:1897–1903. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Prasad TK and Rao NM: The role of plasmid
constructs containing the SV40 DNA nuclear-targeting sequence in
cationic lipid-mediated DNA delivery. Cell Mol Biol Lett.
10:203–215. 2005.PubMed/NCBI
|
|
13
|
Gonçalves C, Ardourel MY, Decoville M,
Breuzard G, Midoux P, Hartmann B and Pichon C: An optimized
extended DNA kappa B site that enhances plasmid DNA nuclear import
and gene expression. J Gene Med. 11:401–411. 2009.PubMed/NCBI
|
|
14
|
Pérez-Martínez FC, Guerra J, Posadas I and
Ceña V: Barriers to non-viral vector-mediated gene delivery in the
nervous system. Pharm Res. 28:1843–1858. 2011.PubMed/NCBI
|
|
15
|
Xie A, Belcik T, Qi Y, et al:
Ultrasound-mediated vascular gene transfection by cavitation of
endothelial-targeted cationic microbubbles. JACC Cardiovasc
Imaging. 5:1253–1262. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cavalli R, Bisazza A, Trotta M, Argenziano
M, Civra A, Donalisio M and Lembo D: New chitosan nanobubbles for
ultrasound-mediated gene delivery: preparation and in vitro
characterization. Int J Nanomedicine. 7:3309–3318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mehier-Humbert S, Bettinger T, Yan F and
Guy RH: Plasma membrane poration induced by ultrasound exposure:
implication for drug delivery. J Control Release. 104:213–222.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Glover DJ, Leyton DL, Moseley GW and Jans
DA: The efficiency of nuclear plasmid DNA delivery is a critical
determinant of transgene expression at the single cell level. Gene
Med. 12:77–85. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Allen TD, Cronshaw JM, Bagley S, Kiseleva
E and Goldberg MW: The nuclear pore complex: mediator of
translocation between nucleus and cytoplasm. J Cell Sci.
113:1651–1659. 2000.PubMed/NCBI
|
|
20
|
Lange A, Mills RE, Lange CJ, Stewart M,
Devine SE and Corbett AH: Classical nuclear localization signals:
definition, function, and interaction with importin alpha. J Biol
Chem. 282:5101–5105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van Gaal EV, Oosting RS, van Eijk R, et
al: DNA nuclear targeting sequences for non-viral gene delivery.
Pharm Res. 28:1707–1722. 2011.PubMed/NCBI
|
|
22
|
Cartier R and Reszka R: Utilization of
synthetic peptides containing nuclear localization signals for
nonviral gene transfer systems. Gene Ther. 9:157–167. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Martin ME and Rice KG: Peptide-guided gene
delivery. AAPS J. 9:E18–E29. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Munkonge FM, Amin V, Hyde SC, et al:
Identification and functional characterization of cytoplasmic
determinants of plasmid DNA nuclear import. J Biol Chem.
284:26978–26987. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeong JH, Kim SH, Christensen LV, Feijen J
and Kim SW: Reducible poly (amido ethylenimine)-based gene delivery
system for improved nucleus trafficking of plasmid DNA. Bioconjug
Chem. 21:296–301. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ghadge SK, Mühlstedt S, Ozcelik C and
Bader M: SDF-1α as a therapeutic stem cell homing factor in
myocardial infarction. Pharmacol Ther. 129:97–108. 2011.
|
|
27
|
Wen J, Zhang JQ, Huang W and Wang Y:
SDF-1α and CXCR4 as therapeutic targets in cardiovascular disease.
Am J Cardiovasc Dis. 2:20–28. 2012.
|
